FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2735949777> ?p ?o ?g. }

• W2735949777 endingPage "26" @default.
• W2735949777 startingPage "22" @default.
• W2735949777 abstract "FOLFIRINOX chemotherapy has shown remarkable responses in patients with metastatic pancreatic cancer (MPC), and has significantly improved prognosis. However, FOLFIRINOX is currently not frequently applied in China because of its high incidence of adverse events, and there is no recognized optimization for this therapy in Chinese population. Modification of FOLFIRINOX may be better for its acceptance in China. In this study, we evaluated the efficacy and safety of modified-FOLFIRINOX in patients with MPC. A total of 62 MPC patients were treated with modified-FOLFIRINOX (no Fluorouracil bolus, 85% Oxaliplatin and 75% Irinotecan) between April 2014 and April 2017 in our institute. 40 of them were evaluated, with a response rate of 32.5% (13/40). The frequent grade 3/4 adverse events are neutropenia (29%) and alanine aminotransferase elevation (14.5%). No treatment-related death was observed. The median overall survival and median progression-free survival are 10.3 months and 7.0 months, respectively. In conclusion, modified-FOLFIRINOX had significantly improved tolerance with similar efficacy to FOLFIRINOX. These findings may provide evidence for the use of FOLFIRINOX in Chinese patients with MPC." @default.
• W2735949777 created "2017-07-21" @default.
• W2735949777 creator A5004111700 @default.
• W2735949777 creator A5007720260 @default.
• W2735949777 creator A5007757417 @default.
• W2735949777 creator A5014336437 @default.
• W2735949777 creator A5016729352 @default.
• W2735949777 creator A5021804564 @default.
• W2735949777 creator A5026680601 @default.
• W2735949777 creator A5027311139 @default.
• W2735949777 creator A5027755989 @default.
• W2735949777 creator A5040527192 @default.
• W2735949777 creator A5041918034 @default.
• W2735949777 creator A5047774145 @default.
• W2735949777 creator A5058212805 @default.
• W2735949777 creator A5060335470 @default.
• W2735949777 creator A5064307000 @default.
• W2735949777 creator A5065221389 @default.
• W2735949777 creator A5065855240 @default.
• W2735949777 creator A5076454806 @default.
• W2735949777 creator A5085378930 @default.
• W2735949777 date "2017-10-01" @default.
• W2735949777 modified "2023-10-17" @default.
• W2735949777 title "Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population" @default.
• W2735949777 cites W1931508686 @default.
• W2735949777 cites W1985988050 @default.
• W2735949777 cites W2019607817 @default.
• W2735949777 cites W2027389238 @default.
• W2735949777 cites W2037565369 @default.
• W2735949777 cites W2037608659 @default.
• W2735949777 cites W2150550712 @default.
• W2735949777 cites W2151253787 @default.
• W2735949777 cites W2152387274 @default.
• W2735949777 cites W2169381459 @default.
• W2735949777 cites W2170552969 @default.
• W2735949777 cites W2272984102 @default.
• W2735949777 cites W2317504614 @default.
• W2735949777 cites W2323248054 @default.
• W2735949777 cites W2345822778 @default.
• W2735949777 cites W2480793872 @default.
• W2735949777 cites W2520774580 @default.
• W2735949777 doi "https://doi.org/10.1016/j.canlet.2017.07.012" @default.
• W2735949777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28729048" @default.
• W2735949777 hasPublicationYear "2017" @default.
• W2735949777 type Work @default.
• W2735949777 sameAs 2735949777 @default.
• W2735949777 citedByCount "48" @default.
• W2735949777 countsByYear W27359497772018 @default.
• W2735949777 countsByYear W27359497772019 @default.
• W2735949777 countsByYear W27359497772020 @default.
• W2735949777 countsByYear W27359497772021 @default.
• W2735949777 countsByYear W27359497772022 @default.
• W2735949777 countsByYear W27359497772023 @default.
• W2735949777 crossrefType "journal-article" @default.
• W2735949777 hasAuthorship W2735949777A5004111700 @default.
• W2735949777 hasAuthorship W2735949777A5007720260 @default.
• W2735949777 hasAuthorship W2735949777A5007757417 @default.
• W2735949777 hasAuthorship W2735949777A5014336437 @default.
• W2735949777 hasAuthorship W2735949777A5016729352 @default.
• W2735949777 hasAuthorship W2735949777A5021804564 @default.
• W2735949777 hasAuthorship W2735949777A5026680601 @default.
• W2735949777 hasAuthorship W2735949777A5027311139 @default.
• W2735949777 hasAuthorship W2735949777A5027755989 @default.
• W2735949777 hasAuthorship W2735949777A5040527192 @default.
• W2735949777 hasAuthorship W2735949777A5041918034 @default.
• W2735949777 hasAuthorship W2735949777A5047774145 @default.
• W2735949777 hasAuthorship W2735949777A5058212805 @default.
• W2735949777 hasAuthorship W2735949777A5060335470 @default.
• W2735949777 hasAuthorship W2735949777A5064307000 @default.
• W2735949777 hasAuthorship W2735949777A5065221389 @default.
• W2735949777 hasAuthorship W2735949777A5065855240 @default.
• W2735949777 hasAuthorship W2735949777A5076454806 @default.
• W2735949777 hasAuthorship W2735949777A5085378930 @default.
• W2735949777 hasBestOaLocation W27359497771 @default.
• W2735949777 hasConcept C121608353 @default.
• W2735949777 hasConcept C126322002 @default.
• W2735949777 hasConcept C143998085 @default.
• W2735949777 hasConcept C188816634 @default.
• W2735949777 hasConcept C2777148230 @default.
• W2735949777 hasConcept C2780210213 @default.
• W2735949777 hasConcept C2780962732 @default.
• W2735949777 hasConcept C2908647359 @default.
• W2735949777 hasConcept C526805850 @default.
• W2735949777 hasConcept C71924100 @default.
• W2735949777 hasConcept C99454951 @default.
• W2735949777 hasConceptScore W2735949777C121608353 @default.
• W2735949777 hasConceptScore W2735949777C126322002 @default.
• W2735949777 hasConceptScore W2735949777C143998085 @default.
• W2735949777 hasConceptScore W2735949777C188816634 @default.
• W2735949777 hasConceptScore W2735949777C2777148230 @default.
• W2735949777 hasConceptScore W2735949777C2780210213 @default.
• W2735949777 hasConceptScore W2735949777C2780962732 @default.
• W2735949777 hasConceptScore W2735949777C2908647359 @default.
• W2735949777 hasConceptScore W2735949777C526805850 @default.
• W2735949777 hasConceptScore W2735949777C71924100 @default.
• W2735949777 hasConceptScore W2735949777C99454951 @default.
• W2735949777 hasFunder F4320321001 @default.
• W2735949777 hasLocation W27359497771 @default.

• next